Sort
16,300 grants matching “fatty liver disease”
Structure and Function of Enzymes in Fatty Acid Oxidation
$366,843Jung Ja P. Kim · Medical College Of Wisconsin · R01 · FY2009 · GM
Role of Uhrf1 in Liver Development, Regeneration and Carciogenesis
$366,781Chinweike Ukomadu · Brigham And Women'S Hospital · R01 · FY2012 · DK
Clinical Core
$366,714Andrew P Goldberg · University Of Maryland Baltimore · P30 · FY2008 · DK
Role of Uhrf1 in Liver Development, Regeneration and Carciogenesis
$366,696Chinweike Ukomadu · Brigham And Women'S Hospital · R01 · FY2011 · DK
Effects of amino acids on regional lipid metabolism
$366,695Elisabet Borsheim · Arkansas Children'S Hospital Res Inst · R01 · FY2013 · AG
Integration of Circadian Rhythm and Metabolism through Coactivator PGC-1alpha
$366,630Jiandie D Lin · University Of Michigan At Ann Arbor · R01 · FY2011 · HL
Integration of Circadian Rhythm and Metabolism through Coactivator PGC-1alpha
$366,630Jiandie D Lin · University Of Michigan At Ann Arbor · R01 · FY2009 · HL
Integration of Circadian Rhythm and Metabolism through Coactivator PGC-1alpha
$366,630Jiandie D Lin · University Of Michigan At Ann Arbor · R01 · FY2010 · HL
Noninvasive Monitoring of Hepatic Glutathione Depletion Through Blood Test
$366,563Jie Zheng · University Of Texas Dallas · R01 · FY2021 · DK
The Role of Mitochondrial Dysfunction in Non-Alcoholic Fatty Liver Disease
$366,541Jeffrey D Browning · Ut Southwestern Medical Center · R01 · FY2015 · DK
The role of GHS-R in macrophage reprogramming during meta-inflammation
$366,431Yuxiang Sun · Texas A&M Agrilife Research · R56 · FY2018 · DK
Macrophage, ABCA1, Inflammation, and Atherosclerosis
$366,300John S Parks · Wake Forest University Health Sciences · R01 · FY2012 · HL
Inflammation, Atherosclerosis and ApoA-I
$366,300Mary G Sorci-Thomas · Wake Forest University Health Sciences · R01 · FY2012 · HL
Cefalu: Project 1; Botanicals and Metabolic Flexibility (Cefalu)
$366,263William T. Cefalu · Lsu Pennington Biomedical Research Ctr · P50 · FY2017 · AT
Cefalu: Project 1; Botanicals and Metabolic Flexibility (Cefalu)
$366,263William T. Cefalu · Lsu Pennington Biomedical Research Ctr · P50 · FY2019 · AT
LXR and human ApoE isoform effects on AD phenotype: in vitro and in vivo models
$366,252Radosveta P Koldamova · University Of Pittsburgh At Pittsburgh · R01 · FY2014 · AG
Hepatic Insulin Resistance Following Hemorrhage
$366,250Joseph Louis Messina · University Of Alabama At Birmingham · R01 · FY2010 · DK
Sources and effects of angiotensin peptides in atherosclerosis
$366,250Alan Daugherty · University Of Kentucky · R01 · FY2009 · HL
Sources and effects of angiotensin peptides in atherosclerosis
$366,250Alan Daugherty · University Of Kentucky · R01 · FY2011 · HL
Asymmetric Distribution of Cholesterol in Membranes
$366,250Friedhelm Schroeder · Texas A&M Agrilife Research · R01 · FY2009 · GM
Asymmetric Distribution of Cholesterol in Membranes
$366,250Friedhelm Schroeder · Texas A&M Agrilife Research · R01 · FY2010 · GM
Sources and effects of angiotensin peptides in atherosclerosis
$366,250Alan Daugherty · University Of Kentucky · R01 · FY2010 · HL
Hepatic Stellate Cell Activation induced by Hepatitis C Virus
$366,247David A Brenner · University Of California, San Diego · R01 · FY2007 · AA
The Evolution of PGD addiction in Human Pancreatic Cancer
$366,237Oliver Gene McDonald · Vanderbilt University Medical Center · R01 · FY2020 · CA
Angll and PPARy/LXR in Atherosclerosis
$366,235Willa A. Hsueh · University Of California Los Angeles · R01 · FY2007 · HL